African Dress Code
News

Nigeria has a ?Madagascar herb? plantation – Minister of Health, Ehanire Osagie

Dr Osagie Ehanire, Nigeria’s Minister of Health has disclosed that Nigeria already has a plantation of herbs used to produce Madagascar’s ‘COVID Organics’. 

 

Speaking during a Presidential Task Force on COVID-19 briefing, Ehanire said an analysis of Madagascar’s ‘COVID Organics’ shows that the mixture contains largely anti-malarial constituents. 

 

The Minister added that relevant agencies will further evaluate the herb to determine its effectiveness in treating COVID-19.

 

Ehanire said; 

 

“Preliminary results of the analysis of the so-called Madagascar herbs by the National Institute for Pharmaceutical Research and Development (NIPRD) shows that it is the same as the plant Artemisia anua, which is grown in the NIPRD farm.

“Further research on its efficacy will be conducted when the grants for research are approved.

“The so-called Madagascar herb is one component of the malaria treatment medicine.

“Some years ago, the government imported this plant and has a plantation of it in trying to develop its production of the artemisinin-based combination therapy (ACT).

“The plantation is still there, but the process has not gone that much further.

“We are looking into seeing what has held it up, but the plant is here; it was intended for producing anti-malarial, and the type we have here has a very high yield of artemisinin, which is the active ingredient.

“The species we have here have been tested and they have a very high concentration of artemisinin.

“To see whether it works against the coronavirus disease is what further research will have to bring.”

Related posts

Photos: Check Out How Hunger Forced Nigerian Man To Prepare Meal With Frog

Astrid Kana

Actor, Brown Igboegwu narrates how he was mocked and advised to get another woman pregnant as he and his wife welcome a child after 10 years of marriage

Astrid Kana

From Ice Cream To Toilet Seats: The Most Bizarre Uses For Gold

Astrid Kana

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy